Works by Hoti, Fabian

Results: 34
    1
    2
    3

    Validation of safety outcomes in routinely collected data: Lessons learned from a multinational postapproval safety study.

    Published in:
    Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 5, p. 592, doi. 10.1002/pds.5582
    By:
    • Arena, Patrick J.;
    • Huang, Kui;
    • Löfling, Lukas;
    • Bahmanyar, Shahram;
    • Mo, Jingping;
    • Schachterle, Stephen E.;
    • Nunes, Anthony P.;
    • Smits, Elisabeth;
    • Juuti, Rosa;
    • Hoti, Fabian;
    • Korhonen, Pasi;
    • Adelborg, Kasper;
    • Sundbøll, Jens;
    • Rasmussen, Torben Riis;
    • Løkke, Anders;
    • Ehrenstein, Vera
    Publication type:
    Article
    4

    Outcomes in patients with lung cancer treated with crizotinib and erlotinib in routine clinical practice: A post‐authorization safety cohort study conducted in Europe and in the United States.

    Published in:
    Pharmacoepidemiology & Drug Safety, 2021, v. 30, n. 6, p. 758, doi. 10.1002/pds.5193
    By:
    • Ehrenstein, Vera;
    • Huang, Kui;
    • Kahlert, Johnny;
    • Bahmanyar, Shahram;
    • Karlsson, Pär;
    • Löfling, Lukas;
    • Nunes, Anthony P.;
    • Enger, Cheryl;
    • Bezemer, Irene D.;
    • Kuiper, Josephina G.;
    • Hoti, Fabian;
    • Juuti, Rosa;
    • Korhonen, Pasi;
    • Mo, Jingping;
    • Schachterle, Stephen E.;
    • Wilner, Keith D.;
    • Rørth, Mikael;
    • Sørensen, Henrik T.
    Publication type:
    Article
    5

    Prenatal exposure to pregabalin, birth outcomes and neurodevelopment – a population-based cohort study in four Nordic countries.

    Published in:
    Drug Safety, 2023, v. 46, n. 7, p. 661, doi. 10.1007/s40264-023-01307-2
    By:
    • Dudukina, Elena;
    • Szépligeti, Szimonetta Komjáthiné;
    • Karlsson, Pär;
    • Asomaning, Kofi;
    • Daltveit, Anne Kjersti;
    • Hakkarainen, Katja;
    • Hoti, Fabian;
    • Kieler, Helle;
    • Lunde, Astrid;
    • Odsbu, Ingvild;
    • Rantanen, Matti;
    • Reutfors, Johan;
    • Saarelainen, Laura;
    • Ehrenstein, Vera;
    • Toft, Gunnar
    Publication type:
    Article
    6
    7

    Metagenes Associated with Survival in Non-Small Cell Lung Cancer.

    Published in:
    Cancer Informatics, 2011, n. 10, p. 175, doi. 10.4137/CIN.S7135
    By:
    • Urgard, Egon;
    • Vooder51, Tõnu;
    • Võsa, Urmo;
    • Välk, Kristjan;
    • Mingming Liu;
    • Cheng Luo;
    • Hoti, Fabian;
    • Roosipuu, Retlav;
    • Annilo, Tarmo;
    • Laine, Jukka;
    • Frenz, Christopher M.;
    • Zhang, Liqing;
    • Metspalu, Andres
    Publication type:
    Article
    8

    Metagenes Associated with Survival in Non-Small Cell Lung Cancer.

    Published in:
    Cancer Informatics, 2011, n. 9, p. 175, doi. 10.4137/CIN.S7135
    By:
    • Urgard, Egon;
    • Vooder, Tõnu;
    • Võsa, Urmo;
    • Välk, Kristjan;
    • Mingming Liu;
    • Cheng Luo;
    • Hoti, Fabian;
    • Roosipuu, Retlav;
    • Annilo, Tarmo;
    • Laine, Jukka;
    • Frenz, Christopher M.;
    • Liqing Zhang;
    • Andres Metspalu
    Publication type:
    Article
    9
    10
    11
    12
    13
    14

    Empagliflozin Use Is Associated With Lower Risk of All‐Cause Mortality, Hospitalization for Heart Failure, and End‐Stage Renal Disease Compared to DPP‐4i in Nordic Type 2 Diabetes Patients: Results From the EMPRISE (Empagliflozin Comparative Effectiveness and Safety) Study

    Published in:
    Journal of Diabetes Research, 2024, v. 2024, p. 1, doi. 10.1155/2024/6142211
    By:
    • Langslet, Gisle;
    • Nyström, Thomas;
    • Vistisen, Dorte;
    • Carstensen, Bendix;
    • Grip, Emilie Toresson;
    • Casajust, Paula;
    • Tskhvarashvili, Giorgi;
    • Hoti, Fabian;
    • Klement, Riho;
    • Karlsdotter, Kristina;
    • Tuovinen, Mikko;
    • Ofstad, Anne Pernille;
    • Lajer, Maria;
    • Shay, Christina;
    • Koeneman, Lisette;
    • Farsani, Soulmaz Fazeli;
    • Niskanen, Leo;
    • Halvorsen, Sigrun;
    • Infante, Marco
    Publication type:
    Article
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25

    Long-Term Safety of Roflumilast in Patients with Chronic Obstructive Pulmonary Disease, a Multinational Observational Database Cohort Study.

    Published in:
    International Journal of COPD, 2024, v. 19, p. 1879, doi. 10.2147/COPD.S465517
    By:
    • Garbe, Edeltraut;
    • Hoti, Fabian;
    • Schink, Tania;
    • Svendsen, Kristian;
    • Al-Eid, Haydar;
    • Arkhammar, Per;
    • Carlholm, Marie;
    • Fjällbrant, Harald;
    • Franzén, Stefan;
    • Hedlund, Cecilia;
    • Kollhorst, Bianca;
    • Kumar, Atul;
    • Lobier, Muriel;
    • Mushnikov, Vasili;
    • Persson, Tore;
    • Qiao, Xu;
    • Salosensaari, Aaro;
    • Schäfer, Wiebke;
    • Sicignano, Nicholas M;
    • Johansson, Gunnar
    Publication type:
    Article
    26

    Risk of cardiovascular events after an exacerbation of chronic obstructive pulmonary disease: results from the EXACOS-CV cohort study using the PHARMO Data Network in the Netherlands.

    Published in:
    Respiratory Research, 2023, v. 24, n. 1, p. 1, doi. 10.1186/s12931-023-02601-4
    By:
    • Swart, Karin M. A.;
    • Baak, Brenda N.;
    • Lemmens, Louise;
    • Penning-van Beest, Fernie J. A.;
    • Bengtsson, Camilla;
    • Lobier, Muriel;
    • Hoti, Fabian;
    • Vojinovic, Dina;
    • van Burk, Lindy;
    • Rhodes, Kirsty;
    • Garbe, Edeltraut;
    • Herings, Ron M. C.;
    • Nordon, Clementine;
    • Simons, Sami O.
    Publication type:
    Article
    27
    28
    29
    30
    31
    32
    33

    Evaluating the Effectiveness of an Additional Risk Minimization Measure to Reduce the Risk of Prescribing Mirabegron to Patients with Severe Uncontrolled Hypertension in Four European Countries.

    Published in:
    Clinical Epidemiology, 2020, v. 12, p. 423, doi. 10.2147/CLEP.S242065
    By:
    • Heintjes, Edith M;
    • Bezemer, Irene D;
    • Prieto-Alhambra, Daniel;
    • Smits, Elisabeth;
    • Booth, Helen P;
    • Dedman, Daniel;
    • He, Ying;
    • Hoti, Fabian;
    • Vehkala, Minna;
    • Vogel, Stefan de;
    • Robinson, Noah Jamie;
    • Appenteng, Kwame;
    • Beest, Fernie JA Penning-van
    Publication type:
    Article
    34